K
Kevin J. Clerkin
Researcher at Columbia University
Publications - 122
Citations - 3354
Kevin J. Clerkin is an academic researcher from Columbia University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 19, co-authored 60 publications receiving 2253 citations. Previous affiliations of Kevin J. Clerkin include Columbia University Medical Center & Stevens Institute of Technology.
Papers
More filters
Journal ArticleDOI
COVID-19 and Cardiovascular Disease.
Kevin J. Clerkin,Justin Fried,Jayant Raikhelkar,Gabriel Sayer,Jan M. Griffin,Amirali Masoumi,Sneha S. Jain,Daniel Burkhoff,Deepa Kumaraiah,Le Roy E. Rabbani,Allan Schwartz,Nir Uriel +11 more
TL;DR: COVID-19 poses a challenge for heart transplantation, affecting donor selection, immunosuppression, and posttransplant management, and there are a number of promising therapies under active investigation to treat and prevent the disease.
Journal ArticleDOI
The Variety of Cardiovascular Presentations of COVID-19.
Justin Fried,Kumudha Ramasubbu,Reema Bhatt,Veli K. Topkara,Kevin J. Clerkin,Evelyn M. Horn,Le Roy E. Rabbani,Daniel Brodie,Sneha S. Jain,Ajay J. Kirtane,Amirali Masoumi,Koji Takeda,Deepa Kumaraiah,Daniel Burkhoff,Martin B. Leon,Allan Schwartz,Nir Uriel,Gabriel Sayer +17 more
TL;DR: Information about a real patient is presented in stages (boldface type) to expert clinicians (Drs Uriel and Sayer), who respond to the information and share their reasoning with the reader (regular type).
Journal ArticleDOI
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Behnood Bikdeli,Behnood Bikdeli,Mahesh V. Madhavan,Aakriti Gupta,Aakriti Gupta,David Jiménez,John R. Burton,Caroline Der Nigoghossian,Taylor Chuich,Shayan Nabavi Nouri,Isaac Dreyfus,Elissa Driggin,Sanjum S. Sethi,Kartik Sehgal,Kartik Sehgal,Saurav Chatterjee,Walter Ageno,Mohammad Madjid,Yutao Guo,Yutao Guo,Liang V. Tang,Yu Hu,Laurent Bertoletti,Jay Giri,Jay Giri,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Alfonso Tafur,Alfonso Tafur,Dominic P. Francese,Jaya Batra,Anna Falanga,Kevin J. Clerkin,Nir Uriel,Ajay J. Kirtane,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,Ido Weinberg,Sam Schulman,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,Martin B. Leon,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +65 more
TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.
Journal ArticleDOI
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.
Farhana Latif,Maryjane Farr,Kevin J. Clerkin,Marlena V. Habal,Koji Takeda,Yoshifumi Naka,Susan Restaino,Gabriel Sayer,Nir Uriel +8 more
TL;DR: In this single-center case series, COVID-19 infection was associated with a case fatality rate of 25% in recipients of HT and was reduced in most of this group of patients.
Journal ArticleDOI
Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation
Kevin J. Clerkin,Maryjane Farr,Susan Restaino,Emmanuel Zorn,Farhana Latif,Elena R. Vasilescu,Charles C. Marboe,Paolo C. Colombo,Donna M. Mancini +8 more
TL;DR: DSA were inadequate to diagnose pAMR, and Class II DSA provided prognostic information regarding future p AMR, graft dysfunction with pAMr, and graft loss.